Anthony Catalano
Chief Operating Officer bei ISOPLEXIS CORPORATION
Profil
Anthony Catalano is a Senior Vice President-Operations at IsoPlexis Corp.
He previously worked as a Senior Director-Operations at Revvity, Inc. and VisEn Medical, Inc. He also worked as a Principal at ETEX Corp.
and Nova Biomedical Corp.
Catalano completed his undergraduate degree at Brandeis University.
Aktive Positionen von Anthony Catalano
Unternehmen | Position | Beginn |
---|---|---|
ISOPLEXIS CORPORATION | Chief Operating Officer | 12.11.2021 |
Ehemalige bekannte Positionen von Anthony Catalano
Unternehmen | Position | Ende |
---|---|---|
REVVITY, INC. | Corporate Officer/Principal | - |
Nova Biomedical Corp.
Nova Biomedical Corp. Medical SpecialtiesHealth Technology Nova Biomedical Corp. develops and manufactures blood analyzers. Its products include automated chemistry analyzers for analysis of nutrients, metabolites, and gases in cell culture and fermentation. The company was founded in 1976 by Robert L. Coleman and is headquartered in Waltham, MA. | Corporate Officer/Principal | - |
ETEX Corp.
ETEX Corp. Chemicals: Major DiversifiedProcess Industries Etex Corp. manufactures calcium phosphate biomaterials. Its products are used for bone graft substitutes, reconstruction of skeletal defects, orthopedic, spine indications, and orthopedic implants. The company was founded by D. Duke Lee in 1989 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
VisEn Medical, Inc.
VisEn Medical, Inc. Medical/Nursing ServicesHealth Services VisEn's in vivo fluorescence imaging technologies, including its Fluorescence Agent Portfolio and its Fluorescence Molecular Tomographic (FMTTM) Imaging Systems provide robust fluorescence molecular imaging performance in identifying, characterizing and quantifying ranges of disease biomarkers and therapeutic efficacy in vivo. VisEn's FMT systems and agents are used by leading research institutions and pharmaceutical companies in applications including cancer research, inflammation, cardiovascular, skeletal and pulmonary disease. The company also works with large pharmaceutical partners to design ranges of tailored molecular imaging agents and applications that are designed to their specific pre-clinical and clinical research areas. | Chief Operating Officer | - |
Ausbildung von Anthony Catalano
Brandeis University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
REVVITY, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
ETEX Corp.
ETEX Corp. Chemicals: Major DiversifiedProcess Industries Etex Corp. manufactures calcium phosphate biomaterials. Its products are used for bone graft substitutes, reconstruction of skeletal defects, orthopedic, spine indications, and orthopedic implants. The company was founded by D. Duke Lee in 1989 and is headquartered in Cambridge, MA. | Process Industries |
VisEn Medical, Inc.
VisEn Medical, Inc. Medical/Nursing ServicesHealth Services VisEn's in vivo fluorescence imaging technologies, including its Fluorescence Agent Portfolio and its Fluorescence Molecular Tomographic (FMTTM) Imaging Systems provide robust fluorescence molecular imaging performance in identifying, characterizing and quantifying ranges of disease biomarkers and therapeutic efficacy in vivo. VisEn's FMT systems and agents are used by leading research institutions and pharmaceutical companies in applications including cancer research, inflammation, cardiovascular, skeletal and pulmonary disease. The company also works with large pharmaceutical partners to design ranges of tailored molecular imaging agents and applications that are designed to their specific pre-clinical and clinical research areas. | Health Services |
IsoPlexis Corp.
IsoPlexis Corp. Packaged SoftwareTechnology Services IsoPlexis Corp. engages in the development of curative medicines and personalized therapeutics. Its single cell proteomics platform, which includes instruments, chip consumables and software, provides an end-to-end solution to reveal a more complete view of protein function at an individual cellular level. The company was founded by Sean Mackay, Rong Fan, and Kara K. Brower in March 2013 and is headquartered in Branford, CT. | Technology Services |
Nova Biomedical Corp.
Nova Biomedical Corp. Medical SpecialtiesHealth Technology Nova Biomedical Corp. develops and manufactures blood analyzers. Its products include automated chemistry analyzers for analysis of nutrients, metabolites, and gases in cell culture and fermentation. The company was founded in 1976 by Robert L. Coleman and is headquartered in Waltham, MA. | Health Technology |